Tobias Reichmuth – the longevity market is now.
Dr. talks about the importance of translational research in bringing hard science to market, without having to worry about biotech approval.
Last month, we were fortunate enough to be able to attend the Longevity Investors Conference. This key event is for those who are interested in learning more about longevity investments and the exciting directions that the field is moving in. As MIT Tech Review recently put it, LIC brings together academic scientists, biotech companies, and deep-pocketed investor. Millionaires and billionaires are involved.
Tobias Reichmuth is one of those driving forces behind the Longevity Investors Conference. A company builder since the young age of 21, Reichmuth is also one of the founding members of Maximon – the longevity company. Riechmuth, along with Maximon colleague Marc P Bernegger launched the Longevity Investors Conference. We couldn’t miss the opportunity to talk to him about the current market for longevity.
Visit Longevity. Technology — https://bit.ly/3PwtH8Y
Follow the Longevity. Follow Longevity.
Twitter — https://bit.ly/3AMIXuq.
Facebook — https://bit.ly/3z8H1v5
Instagram — https://bit.ly/3IDvVRX
Linkedin — https://bit.ly/3yIfDmf
Source:
